{"id":"https://openalex.org/W7141302133","doi":"https://doi.org/10.55277/rhj.qm7p5g89.3","title":"De Novo Protein Binder Design for Advanced Glycation End Products: A Computational Approach to Targeting Age-Related Glycative Damage (Stage 1 Registered Report)","display_name":"De Novo Protein Binder Design for Advanced Glycation End Products: A Computational Approach to Targeting Age-Related Glycative Damage (Stage 1 Registered Report)","publication_year":2026,"publication_date":"2026-03-27","ids":{"openalex":"https://openalex.org/W7141302133","doi":"https://doi.org/10.55277/rhj.qm7p5g89.3"},"language":"en","primary_location":{"id":"doi:10.55277/rhj.qm7p5g89.3","doi":"https://doi.org/10.55277/rhj.qm7p5g89.3","is_oa":true,"landing_page_url":"https://doi.org/10.55277/rhj.qm7p5g89.3","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"report"},"volume":null,"type":"report","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.55277/rhj.qm7p5g89.3","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081938206","display_name":"Kejun Ying","orcid":"https://orcid.org/0000-0002-1791-6176","observed_orcids":["https://orcid.org/0000-0002-1791-6176"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kejun Ying","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1791-6176","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5081938206"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":0.7788000106811523,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":0.7788000106811523,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10044","display_name":"Protein Structure and Dynamics","score":0.16760000586509705,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-glycation-end-products","display_name":"advanced glycation end products","score":0.996999979019165},{"id":"https://openalex.org/keywords/nepsilon-carboxymethyl-lysine","display_name":"carboxymethyllysine","score":0.9570000171661377},{"id":"https://openalex.org/keywords/de-novo-protein-design","display_name":"de novo protein design","score":0.8569999933242798},{"id":"https://openalex.org/keywords/protein-binders","display_name":"protein binders","score":0.7910000085830688},{"id":"https://openalex.org/keywords/receptor-for-advanced-glycation-end-products","display_name":"receptor for advanced glycation end products","score":0.8539999723434448},{"id":"https://openalex.org/keywords/deep-learning-protein-design","display_name":"deep learning protein design","score":0.7149999737739563},{"id":"https://openalex.org/keywords/yeast-surface-display","display_name":"yeast surface display","score":0.5920000076293945},{"id":"https://openalex.org/keywords/biolayer-interferometry","display_name":"biolayer interferometry","score":0.7549999952316284},{"id":"https://openalex.org/keywords/protein-cross-linking","display_name":"protein cross-linking","score":0.6930000185966492}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5006999969482422},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.34540000557899475},{"id":"https://openalex.org/C147990577","wikidata":"https://www.wikidata.org/wiki/Q25790","display_name":"Glycation","level":3,"score":0.3449999988079071},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2994000017642975},{"id":"https://openalex.org/C2988375501","wikidata":"https://www.wikidata.org/wiki/Q847556","display_name":"Protein stability","level":2,"score":0.287200003862381},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.2865000069141388},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2687000036239624},{"id":"https://openalex.org/C11804247","wikidata":"https://www.wikidata.org/wiki/Q896177","display_name":"Protein\u2013protein interaction","level":2,"score":0.266400009393692},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.26409998536109924},{"id":"https://openalex.org/C28005876","wikidata":"https://www.wikidata.org/wiki/Q189814","display_name":"Endocytosis","level":3,"score":0.23029999434947968}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.55277/rhj.qm7p5g89.3","doi":"https://doi.org/10.55277/rhj.qm7p5g89.3","is_oa":true,"landing_page_url":"https://doi.org/10.55277/rhj.qm7p5g89.3","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"report"},{"id":"doi:10.55277/rhj.qm7p5g89.2","doi":"https://doi.org/10.55277/rhj.qm7p5g89.2","is_oa":true,"landing_page_url":"https://doi.org/10.55277/rhj.qm7p5g89.2","pdf_url":"https://storage.prod.researchhub.com/uploads/papers/users/29831/65c60241-b471-4f1e-8d96-aba305b684c4/De Novo Protein Binder Design for Advanced Glycation End Products A Computational Approach to Targeting Age-Related Glycative Damage (Stage 1 Registered Report).pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"report"},{"id":"doi:10.55277/rhj.qm7p5g89","doi":"https://doi.org/10.55277/rhj.qm7p5g89","is_oa":true,"landing_page_url":"https://doi.org/10.55277/rhj.qm7p5g89","pdf_url":"https://storage.prod.researchhub.com/uploads/papers/users/39648/69ce4c30-e35e-45e9-ae8c-bbf7978b9b2f/De Novo Protein Binder Design for Advanced Glycation End Products A Computational Approach to Targeting Age-Related Glycative Damage (Stage 1 Registered Report).pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"report"}],"best_oa_location":{"id":"doi:10.55277/rhj.qm7p5g89.3","doi":"https://doi.org/10.55277/rhj.qm7p5g89.3","is_oa":true,"landing_page_url":"https://doi.org/10.55277/rhj.qm7p5g89.3","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"report"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310094","display_name":"University of Washington","ror":"https://ror.org/00cvxb145"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7141302133.pdf","grobid_xml":"https://content.openalex.org/works/W7141302133.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W4223542076","https://openalex.org/W4383957026","https://openalex.org/W4392544734","https://openalex.org/W4394749915","https://openalex.org/W4409606556"],"related_works":["https://openalex.org/W7125523983","https://openalex.org/W4416227492","https://openalex.org/W3038085131","https://openalex.org/W2057844010","https://openalex.org/W3000334683","https://openalex.org/W7168287053","https://openalex.org/W2065012620","https://openalex.org/W2106697731","https://openalex.org/W2910525936","https://openalex.org/W2085236754"],"abstract_inverted_index":{"Advanced":[0],"glycation":[1,21],"end":[2,22],"products":[3,23],"(AGEs)":[4],"accumulate":[5],"with":[6,81,130],"age":[7],"and":[8,14,26,58,83,89,109,136,143,162],"contribute":[9],"to":[10,45,133,159],"cardiovascular":[11],"disease,":[12],"neurodegeneration,":[13],"diabetic":[15],"complications":[16],"through":[17,99],"receptor":[18],"for":[19],"advanced":[20],"(RAGE)":[24],"activation":[25],"direct":[27],"protein":[28,43,49,68,135,168],"cross-linking.Despite":[29],"decades":[30],"of":[31,156,176],"research,":[32],"no":[33],"approved":[34],"therapies":[35],"specifically":[36],"target":[37],"AGEs.This":[38],"project":[39],"applies":[40],"deep":[41],"learningbased":[42],"design":[44],"create":[46],"de":[47],"novo":[48],"binders":[50,169],"that":[51,121],"sequester":[52],"carboxymethyllysine":[53],"(CML),":[54],"the":[55,73,153],"most":[56],"abundant":[57],"well-characterized":[59],"AGE":[60,160],"species.Using":[61],"RFdiffusion":[62,157],"All-Atom,":[63],"we":[64],"will":[65,95,112,124,146,163],"generate":[66],"10,000":[67],"scaffold":[69],"designs":[70,94],"conditioned":[71],"on":[72],"CML":[74],"molecular":[75],"structure,":[76],"followed":[77],"by":[78,117],"sequence":[79],"optimization":[80],"ProteinMPNN":[82],"in":[84],"silico":[85],"filtering":[86],"using":[87],"AlphaFold2":[88],"Rosetta.The":[90],"top":[91,110],"100-200":[92],"computational":[93,139],"be":[96,147],"validated":[97],"experimentally":[98],"yeast":[100],"surface":[101],"display":[102],"screening":[103],"against":[104],"CML-modified":[105],"bovine":[106],"serum":[107],"albumin,":[108],"candidates":[111],"undergo":[113],"binding":[114,132],"affinity":[115],"characterization":[116],"biolayer":[118],"interferometry.We":[119],"hypothesize":[120],"this":[122],"pipeline":[123],"yield":[125],"at":[126],"least":[127],"one":[128],"binder":[129],"measurable":[131],"CMLmodified":[134],"sub-micromolar":[137],"affinity.All":[138],"designs,":[140],"experimental":[141],"protocols,":[142],"raw":[144],"data":[145],"made":[148],"openly":[149],"available.This":[150],"work":[151],"represents":[152],"first":[154],"application":[155],"All-Atom":[158],"targeting":[161],"establish":[164],"whether":[165],"computationally":[166],"designed":[167],"can":[170],"serve":[171],"as":[172],"a":[173],"new":[174],"class":[175],"anti-glycation":[177],"therapeutics.":[178]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-03-28T00:00:00"}